ACCESSION: MSBNK-SMB_Measured-HSA001P0157017
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.17, Processed 2025.02.17, Annotated 2025.03.05, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyoshu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 20
COMMENT: RAW_SPEC {'12_posi_14399': {'bp': 407283.0, 'sum': 932915.0}, '14_posi_14421': {'bp': 242115.0, 'sum': 694928.0}, '8_posi_14400': {'bp': 326550.0, 'sum': 803744.0}, '6_posi_14398': {'bp': 331904.0, 'sum': 789284.0}, '10_posi_14400': {'bp': 379519.0, 'sum': 870537.0}, '19_posi_14437': {'bp': 324048.0, 'sum': 730205.0}, '4_posi_14399': {'bp': 372022.0, 'sum': 938161.0}, '16_posi_14418': {'bp': 311473.0, 'sum': 757684.0}, '15_posi_14416': {'bp': 313887.0, 'sum': 823119.0}, '5_posi_14401': {'bp': 327320.0, 'sum': 803047.0}, 'ProcedureBlank_14398': {'bp': 346493.0, 'sum': 906630.0}, '7_posi_14395': {'bp': 355257.0, 'sum': 855325.0}, '13_posi_14398': {'bp': 384600.0, 'sum': 934796.0}, '2_posi_14399': {'bp': 348072.0, 'sum': 857748.0}, '18_posi_14415': {'bp': 348638.0, 'sum': 841193.0}, '9_posi_14398': {'bp': 335553.0, 'sum': 868241.0}, '11_posi_14398': {'bp': 315677.0, 'sum': 863078.0}, '17_posi_14415': {'bp': 326994.0, 'sum': 840899.0}, '3_posi_14402': {'bp': 337717.0, 'sum': 822421.0}, 'BLK02_14398': {'bp': 301626.0, 'sum': 835311.0}}
COMMENT: RETENTION_TIME_STDEV 0.021
COMMENT: PRECURSOR_M/Z_RAW 157.169524
COMMENT: PRECURSOR_M/Z_STDEV 0.000047
COMMENT: PRECURSOR_IN_MS1 mz 157.169863; int 77.558; delta(ppm) 1.476156
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.403; C9H20N2; [M+H]+; delta(ppm) -0.403426
COMMENT: PROPOSED_MF MS-FINDER 2.964; C9H20N2; [M+H]+; delta(ppm) -0.401379
COMMENT: PROPOSED_MF SIRIUS6_Sirius 4.577; C9H20N2; [M+H]+; delta(ppm) -0.401379
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C9H20N2; [M+H]+; delta(ppm) -0.401379
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.822; ITZPOSYADVYECJ-UHFFFAOYSA-N; [M+H]+; N'-cyclohexylpropane-1,3-diamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.822; OQDRWVFVLQMVRE-UHFFFAOYSA-N; [M+H]+; nonanimidamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.822; UMHVJTNVQIDHDE-UHFFFAOYSA-N; [M+H]+; 2-heptylidene-1,1-dimethylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; OQDRWVFVLQMVRE-UHFFFAOYSA-N; [M+H]+; nonanimidamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; UMHVJTNVQIDHDE-UHFFFAOYSA-N; [M+H]+; 2-heptylidene-1,1-dimethylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.287; ITZPOSYADVYECJ-UHFFFAOYSA-N; [M+H]+; N'-cyclohexylpropane-1,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.896; FTVFPPFZRRKJIH-UHFFFAOYSA-N; [M+H]+; 2,2,6,6-tetramethylpiperidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.511; ITZPOSYADVYECJ-UHFFFAOYSA-N; [M+H]+; N'-cyclohexylpropane-1,3-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.633; MJWWNBHUIIRNDZ-UHFFFAOYSA-N; [M+H]+; 1-pentylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.452; FGNRRDAUWGLVRV-UHFFFAOYSA-N; [M+H]+; (1-propan-2-ylpiperidin-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.383; KTNPVRSKFWZJEZ-UHFFFAOYSA-N; [M+H]+; 2,2,6,6-tetramethylpiperidin-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.353; GQSWLZPKSPRYJI-UHFFFAOYSA-N; [M+H]+; 2-(3,5-dimethylpiperidin-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.334; WOYCNJCWZDPJKK-UHFFFAOYSA-N; [M+H]+; 1-methyl-3-(2-methylpropyl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.298; NNFVUEAMGPGPTA-UHFFFAOYSA-N; [M+H]+; N-(piperidin-3-ylmethyl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.297; ITEWBASAHQBZBQ-UHFFFAOYSA-N; [M+H]+; N-(2-pyrrolidin-1-ylethyl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.297; PBGUJJXVCZDTGC-UHFFFAOYSA-N; [M+H]+; 2-ethyl-1-propan-2-ylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.296; RUZPSFUHBCXGLY-UHFFFAOYSA-N; [M+H]+; (1-propylpiperidin-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.293; IOCDAGIYEHKJRS-UHFFFAOYSA-N; [M+H]+; 1-(3-methylbutyl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.283; TYMAJBZHTKCAJJ-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)-N,N-dimethylcyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.280; GPWLJZCPRQGUMM-UHFFFAOYSA-N; [M+H]+; 1-butyl-1,4-diazepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.278; OUCLILLLTYQVKW-UHFFFAOYSA-N; [M+H]+; N-methyl-2-(4-methylpiperidin-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.277; JYVUQGFHFSVKFX-UHFFFAOYSA-N; [M+H]+; 1-(2-methylpropyl)-1,4-diazepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.273; ZXVWFOMYPHVUGO-UHFFFAOYSA-N; [M+H]+; 1-(2-methylpropyl)piperidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.271; HRMBSWWTQBEJHL-UHFFFAOYSA-N; [M+H]+; 1-butylpiperidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.270; QTPGFCVQPIPHFA-UHFFFAOYSA-N; [M+H]+; 1-pentan-2-ylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.265; HNMHXBYSUXFPRP-UHFFFAOYSA-N; [M+H]+; 1-methyl-N-(2-methylpropyl)pyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.265; ZWQDCCSMHQUNBC-UHFFFAOYSA-N; [M+H]+; (1-butylpyrrolidin-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.265; SMPLBVCPNOWSNS-UHFFFAOYSA-N; [M+H]+; [1-(2-methylpropyl)pyrrolidin-3-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.256; ITOYOTJXYAOWBL-UHFFFAOYSA-N; [M+H]+; 3-methyl-2-pyrrolidin-1-ylbutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.233; QKHWUKPTSMULMZ-UHFFFAOYSA-N; [M+H]+; 2-(aminomethyl)-3,3,5-trimethylcyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.232; FXTRRLIESPAUHT-UHFFFAOYSA-N; [M+H]+; 3-(azepan-1-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.212; ADIQUBKLXXCKLT-UHFFFAOYSA-N; [M+H]+; 3-(3-methylpiperidin-1-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.211; OBBYUKKVCZUXOY-UHFFFAOYSA-N; [M+H]+; 1-(azepan-1-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.211; PCSDSPLJOYHMEW-UHFFFAOYSA-N; [M+H]+; 2-(azepan-1-yl)-N-methylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.210; OPSPNTUNGOXOIC-UHFFFAOYSA-N; [M+H]+; 1-(3-methylpiperidin-1-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.210; KJZUUHBRCBCMNK-UHFFFAOYSA-N; [M+H]+; 3-(4-methylpiperidin-1-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.200; MXTNPQHZAUREOU-UHFFFAOYSA-N; [M+H]+; N-cyclopentyl-N',N'-dimethylethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.200; KLMZEKWPJSIPOG-UHFFFAOYSA-N; [M+H]+; 1-(4-methylpiperidin-1-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.197; ZFGCHESRGLETHQ-UHFFFAOYSA-N; [M+H]+; 2-(azocan-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.197; AKORAGHXVCPPSO-UHFFFAOYSA-N; [M+H]+; 2-(2-ethylpiperidin-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.188; IUURUDXVDZPRHL-UHFFFAOYSA-N; [M+H]+; 2-(4-ethylpiperidin-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.186; NHCRTTOTVRWPPF-UHFFFAOYSA-N; [M+H]+; 2-(4,4-dimethylpiperidin-1-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.181; NFTNAOZWHAOMPK-UHFFFAOYSA-N; [M+H]+; 1-tert-butyl-1,4-diazepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.173; RFIUBUOFNHKFMX-UHFFFAOYSA-N; [M+H]+; 5-(aminomethyl)-2,2,4-trimethylcyclopentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.159; ZKUOKKDZVODPCK-UHFFFAOYSA-N; [M+H]+; 2-tert-butyl-1-methylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.159; JUYGOAGUPDFXFA-UHFFFAOYSA-N; [M+H]+; 3-tert-butyl-1-methylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.153; MTKKOXBCEBJDOE-UHFFFAOYSA-N; [M+H]+; 1-tert-butylpiperidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.152; IQCHJZSBIAVNGG-UHFFFAOYSA-N; [M+H]+; N-methyl-1-piperidin-1-ylpropan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.150; XUHUOUMBXWRQQH-UHFFFAOYSA-N; [M+H]+; N-ethyl-2-piperidin-1-ylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.146; AIJCTHFQONDNCC-UHFFFAOYSA-N; [M+H]+; 2-methyl-2-piperidin-1-ylpropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.145; DQQHMRVHTMHDGE-DTORHVGOSA-N; [M+H]+; 2-[(2S,6R)-2,6-dimethylpiperidin-1-yl]ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.144; JALHJUKRXXWMPV-UHFFFAOYSA-N; [M+H]+; 3-piperidin-1-ylbutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; SFNKFWIIQFWXTC-UHFFFAOYSA-N; [M+H]+; 2-methyl-3-piperidin-1-ylpropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; GAESVMYMWLXWCU-UHFFFAOYSA-N; [M+H]+; 2-piperidin-1-ylbutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; RFHOUCSLTXCUGO-UHFFFAOYSA-N; [M+H]+; 2,2,7,7-tetramethyl-1,4-diazepane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.142; VJMNZJDGHQJERT-MRVPVSSYSA-N; [M+H]+; 2-methyl-N-[[(2R)-pyrrolidin-2-yl]methyl]propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.126; FNZNHTIBNDAHFH-UHFFFAOYSA-N; [M+H]+; N'-cyclohexyl-N'-methylethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.125; IVPIAQOAOCEOKM-UHFFFAOYSA-N; [M+H]+; 1-pentan-3-ylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.115; SNZAIGXZGPEBGY-UHFFFAOYSA-N; [M+H]+; 1-tert-butylpiperidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.114; BRTFJGVMCOWIRW-UHFFFAOYSA-N; [M+H]+; 1-cyclohexylpropan-2-ylhydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.114; YNTQDSJCTVCNPU-UHFFFAOYSA-N; [M+H]+; 1-(2-methylbutan-2-yl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.111; DBBKREWGWFNQHZ-UHFFFAOYSA-N; [M+H]+; 1-butan-2-ylpiperidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.110; UXHLFFAPGDGJKW-UHFFFAOYSA-N; [M+H]+; (1-butan-2-ylpyrrolidin-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.110; RZQCGPVZOABCIU-QMMMGPOBSA-N; [M+H]+; (3S)-1-pentan-3-ylpyrrolidin-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.108; QRHQUUUKPRHWRO-UHFFFAOYSA-N; [M+H]+; 1-(2,2-dimethylpropyl)piperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.080; VEEMPJFRZBKMQS-UHFFFAOYSA-N; [M+H]+; (1-tert-butylpyrrolidin-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.936; IYCMYOWBZQNVBV-UHFFFAOYSA-N; [M+H]+; (1-propan-2-ylpiperidin-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.870; ACOXURKIHJSMAC-UHFFFAOYSA-N; [M+H]+; 4-piperidin-1-ylbutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.861; IKTZTXACQRUKHD-UHFFFAOYSA-N; [M+H]+; N-methyl-1-propan-2-ylpiperidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.848; QSUUJNCKEJEANG-UHFFFAOYSA-N; [M+H]+; (1-propylpiperidin-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.847; GATDBLAWLPINOT-UHFFFAOYSA-N; [M+H]+; N-methyl-N-propan-2-ylpiperidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.813; AMTIRUGRJCZISV-VMPITWQZSA-N; [M+H]+; N'-[(E)-3-methylbut-1-enyl]butane-1,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.770; XETCAGQZWBVYMH-UHFFFAOYSA-N; [M+H]+; 2,2-dimethyl-3-pyrrolidin-1-ylpropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.701; OUXRMEUJNPVXMM-UHFFFAOYSA-N; [M+H]+; N,N-diethylpiperidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.698; WGARYFRHBPNMCZ-UHFFFAOYSA-N; [M+H]+; 5-pyrrolidin-1-ylpentan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.696; UILJIUFPKKZQQS-UHFFFAOYSA-N; [M+H]+; 1,2,2,6,6-pentamethylpiperazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.692; VXZJMCUARPMTDY-UHFFFAOYSA-N; [M+H]+; N-[(1-ethylpyrrolidin-2-yl)methyl]ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.692; YSWZWFUGBKCCCN-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-2-piperidin-3-ylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.691; NPSGZUYANLXYQA-UHFFFAOYSA-N; [M+H]+; 2-methyl-4-pyrrolidin-1-ylbutan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.690; GQWULILKFDIEHL-UHFFFAOYSA-N; [M+H]+; 1-ethyl-N,3-dimethylpiperidin-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.680; CFSDKEAIRWMYOL-UHFFFAOYSA-N; [M+H]+; 2-[(dimethylamino)methyl]cyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.680; KNWUQYQKSMAIAQ-UHFFFAOYSA-N; [M+H]+; [1-[(dimethylamino)methyl]cyclopentyl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.672; HOIFYAYAOLSLBR-UHFFFAOYSA-N; [M+H]+; N-ethyl-N-(pyrrolidin-3-ylmethyl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.645; RSFAUZNVDWGQBZ-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-2-piperidin-4-ylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.643; IEQHWSWDQPNZTK-UHFFFAOYSA-N; [M+H]+; 3-(1-methylpiperidin-4-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.635; UXANJKWCNDPIDE-UHFFFAOYSA-N; [M+H]+; 2-(1-ethylpiperidin-4-yl)ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.632; MUMWBHSVKFUMFC-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-1-(4-methylpiperidin-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.630; HJANWHMCHVPVJK-UHFFFAOYSA-N; [M+H]+; 1-N,4-N,4-N-trimethylcyclohexane-1,4-diamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.628; AQRWDLOWHDZKAQ-UHFFFAOYSA-N; [M+H]+; 4-(aminomethyl)-N,N-dimethylcyclohexan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.627; HVEVCNLWVQAPHU-UHFFFAOYSA-N; [M+H]+; 1-N,1-N,1-trimethylcyclohexane-1,4-diamine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C9H21N2; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 28.924
MS$FOCUSED_ION: PRECURSOR_M/Z 157.169862
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0a4i-1900000000-0594be70753d4a9970c4
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  70.0650293 17.3840 70.065649 1.0276 5.53 -0.1422 17 f{C4H8N1}/-1.38ppm,p-C5H13N1
  71.0603778 153.2350 71.060991 0.4362 17.70 0.6000 20 f{C3H7N2}/0.04ppm,p-C6H14
  86.0599086 22.5428 86.060375 1.2433 8.21 -0.3053 19 ?
  87.0917054 84.1169 87.092158 0.7463 11.19 0.3624 20 f{C4H11N2}/0.35ppm,p-C5H10
  113.1073323 110.1711 113.107525 0.9018 36.12 0.3444 20 f{C6H13N2}/0.07ppm,p-C3H8
  114.0911890 25.0423 114.091371 1.7179 5.88 0.0526 20 ?
  114.1027267 64.3316 114.102908 1.4811 9.86 -0.0692 20 ?
  114.1101208 17.3094 114.110303 2.3924 1.96 0.5263 19 ?
  129.1021827 26.7165 129.102166 1.4020 6.81 -0.0872 20 ?
  157.0609437 34.5977 157.060837 2.5086 29.71 -0.0782 20 ?
  157.0971322 276.4571 157.097026 0.4647 34.88 0.2692 20 ?
  157.1337228 40.6911 157.133616 1.4701 8.31 -0.0918 20 ?
  157.1447963 500.1357 157.144689 0.4454 51.50 0.3489 20 ?
  157.1699183 999.0000 157.169812 0.2863 0.00 1.0000 20 f{C9H21N2}/-0.04ppm,p
PK$NUM_PEAK: 14
PK$PEAK: m/z int. rel.int.
  70.065029 17.38 17
  71.060378 153.24 153
  86.059909 22.54 22
  87.091705 84.12 84
  113.107332 110.17 110
  114.091189 25.04 25
  114.102727 64.33 64
  114.110121 17.31 17
  129.102183 26.72 26
  157.060944 34.60 34
  157.097132 276.46 276
  157.133723 40.69 40
  157.144796 500.14 500
  157.169918 999.00 999
//
